ArticleJournal for immunotherapy of cancer2025

Correction: Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.